Hans Edgar Bishop - Oct 5, 2023 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
Director
Signature
/s/ Julie Shah, Attorney-in-Fact for Hans Edgar Bishop
Stock symbol
SANA
Transactions as of
Oct 5, 2023
Transactions value $
$0
Form type
4
Date filed
10/6/2023, 04:20 PM
Previous filing
Sep 8, 2023
Next filing
Jan 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SANA Common Stock Award $0 +6.93K +0.12% $0.00 5.77M Oct 5, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of fully vested restricted stock units for which the Reporting Person has elected to defer settlement until January 1, 2024 pursuant to Sana Biotechnology, Inc.'s Non-Employee Director Compensation Program.